Cutting-edge biotech production facility planned in Debrecen
Debrecen/Budapest – Hungary’s leading pharmaceutical company Gedeon Richter Plc. is continuing to expand its activities in biotechnological R&D and manufacturing of therapeutic proteins. After the establishment of Richter-Helm in Germany, a joint venture of Gedeon Richter and Hamburg-based Helm AG one year ago, the Hungarian company announced in August that it will build a a63m multi-purpose plant for the production of biopharmaceuticals in insect and mammalian cells at Debrecen. The company says that the novel unit, which will create 110 new jobs and is expected to be operational by 2012, will be “one of kind in Central and Eastern Europe, and will also be a significant step forward in enhancing the competitiveness of Hungary.”
Plant to go online by 2012
Gedeon Richter, which will start construction of the new production plant in Debrecen’s industrial park this year, did not discuss how much money the Hungarian government will contribute to the prestigous project. But local authorities might have sold Richter the land under market prices and granted a local tax concession, according to reports from the regional press.
Besides the production of therapeutic proteins in insect and mammalian cells, the GMP-compliant plant will also be suitable for other technologies with minimal modification, according to Gedeon Richter. Initially, the new site will produce clinical trials materials, but from 2014 the company plans to switch to production of drugs for the pharmaceutical market.